Recent Blog Articles

Heart Beat: Testing a no-warfarin heart valve

April 01, 2006

Heart Beat

Testing a no-warfarin heart valve

Having a heart valve replaced means making a tricky trade-off: Do you choose a mechanical model that can last 30 years or more but requires that you take warfarin to prevent small clots that can form on the device? Or do you choose a biological valve that will wear out in 10–15 years but doesn't require that you take warfarin?

A company called Medical Carbon Research Institute hopes to make that choice a thing of the past. The FDA has okayed a clinical trial of the company's On-X valve with reduced anticoagulation. Volunteers at low risk for clots will take aspirin and clopidogrel (Plavix), not warfarin, to prevent clots after getting a new valve. Success of the trial could mean we finally have a "valve for life," says Dr. Sidney Levitsky, a Harvard professor of surgery who is helping oversee the trial.

To continue reading this article, you must log in.

Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.

  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »

I'd like to receive access to Harvard Health Online for only $4.99 a month.

Sign Me Up

Already a member? Login ».

Disclaimer:

As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.